FDA Inspection 1182260 — Broncolin, S.A. De C.V.

Broncolin, S.A. De C.V. — FEI 3009331372

The FDA completed an inspection of Broncolin, S.A. De C.V. on Oct 28, 2022 in Ciudad De Mexico. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Oct 28, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ciudad De Mexico (Mexico)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
136121 CFR 211.100(a)Absence of Written Procedures
189021 CFR 211.165(e)Test methods
430521 CFR 211.68(b)Backup data not assured as exact and complete
434521 CFR 211.160(b)(1)Samples (various types) representative, identified properly
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.